Home › Osteoarthritis › NCT04210284
Oral Nutritional Optimization in Total Joint Arthroplasty
Recruiting
Who can join
Ages 55 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Patient are current candidates for elective primary total hip and total knee arthroplasty 2. Patients ≥55 years of age but ≤ 95 3. Patients who meet at least one of the following three laboratory criteria for malnutrition: TSerum Albumin: ≤3.5 mg/dl Pre-Albumin: \<15 mg/dl Transferrin: \<200 mg/dl Exclusion Criteria: 1. Previous history of septic arthritis 2. Allergy to oral supplementation 3. Inability to consume oral supplementation 4. Protein malabsorption syndromes 5. Eating disorders 6. End stage renal and hepatic disease 7. Revision surgery, non-elective surgery, hemiarthroplasty, and unicompartmental knee arthroplasty
About the study
The purpose of this study is to determine the effect on hematological markers of nutritional intervention on nutritionally deficient patients following total joint replacement surgery.
What is being tested
- Ensure (dietary supplement)
Sponsor: NYU Langone Health · Participants: 72 · Started: Jul 6, 2021
Contact the study team
- Daniel Waren · Phone: 212-598-6245
Official record on ClinicalTrials.gov — NCT04210284
Locations in the U.S.
| New York | NYU Langone Health, New York |
| Pennsylvania | Rothman Orthopedic Institute, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.